165 related articles for article (PubMed ID: 15051827)
1. Krüppel-like factor 4 is transactivated by butyrate in colon cancer cells.
Chen ZY; Rex S; Tseng CC
J Nutr; 2004 Apr; 134(4):792-8. PubMed ID: 15051827
[TBL] [Abstract][Full Text] [Related]
2. Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif.
Shie JL; Chen ZY; Fu M; Pestell RG; Tseng CC
Nucleic Acids Res; 2000 Aug; 28(15):2969-76. PubMed ID: 10908361
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells.
Bai L; Merchant JL
J Biol Chem; 2000 Sep; 275(39):30725-33. PubMed ID: 10899165
[TBL] [Abstract][Full Text] [Related]
4. STAT1 is required for IFN-gamma-mediated gut-enriched Krüppel-like factor expression.
Chen ZY; Shie JL; Tseng CC
Exp Cell Res; 2002 Nov; 281(1):19-27. PubMed ID: 12441126
[TBL] [Abstract][Full Text] [Related]
5. Gut-enriched Kruppel-like factor represses ornithine decarboxylase gene expression and functions as checkpoint regulator in colonic cancer cells.
Chen ZY; Shie JL; Tseng CC
J Biol Chem; 2002 Nov; 277(48):46831-9. PubMed ID: 12297499
[TBL] [Abstract][Full Text] [Related]
6. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
Mikkelsen IM; Huseby NE; Visvikis A; Moens U
Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
[TBL] [Abstract][Full Text] [Related]
7. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
Kim YH; Park JW; Lee JY; Kwon TK
Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
[TBL] [Abstract][Full Text] [Related]
8. Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation.
Shie JL; Chen ZY; O'Brien MJ; Pestell RG; Lee ME; Tseng CC
Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G806-14. PubMed ID: 11005769
[TBL] [Abstract][Full Text] [Related]
9. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
Walker GE; Wilson EM; Powell D; Oh Y
Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of the rat laminin gamma1 chain promoter by the gut-enriched Kruppel-like factor (GKLF/KLF4) and Sp1.
Higaki Y; Schullery D; Kawata Y; Shnyreva M; Abrass C; Bomsztyk K
Nucleic Acids Res; 2002 Jun; 30(11):2270-9. PubMed ID: 12034813
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
12. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line.
Nakano K; Mizuno T; Sowa Y; Orita T; Yoshino T; Okuyama Y; Fujita T; Ohtani-Fujita N; Matsukawa Y; Tokino T; Yamagishi H; Oka T; Nomura H; Sakai T
J Biol Chem; 1997 Aug; 272(35):22199-206. PubMed ID: 9268365
[TBL] [Abstract][Full Text] [Related]
13. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
14. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
Choi HS; Lee JH; Park JG; Lee YI
Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
[TBL] [Abstract][Full Text] [Related]
15. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.
Stone CD; Chen ZY; Tseng CC
FEBS Lett; 2002 Oct; 530(1-3):147-52. PubMed ID: 12387883
[TBL] [Abstract][Full Text] [Related]
16. The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.
Wang H; Yang L; Jamaluddin MS; Boyd DD
J Biol Chem; 2004 May; 279(21):22674-83. PubMed ID: 15031282
[TBL] [Abstract][Full Text] [Related]
17. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
[TBL] [Abstract][Full Text] [Related]
18. Kruppel-like factor 4 (KLF4) represses histidine decarboxylase gene expression through an upstream Sp1 site and downstream gastrin responsive elements.
Ai W; Liu Y; Langlois M; Wang TC
J Biol Chem; 2004 Mar; 279(10):8684-93. PubMed ID: 14670968
[TBL] [Abstract][Full Text] [Related]
19. Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Kruppel-like factor.
Hinnebusch BF; Siddique A; Henderson JW; Malo MS; Zhang W; Athaide CP; Abedrapo MA; Chen X; Yang VW; Hodin RA
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G23-30. PubMed ID: 12919939
[TBL] [Abstract][Full Text] [Related]
20. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells.
Archer SY; Meng S; Shei A; Hodin RA
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6791-6. PubMed ID: 9618491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
